Logo image of IPOF

SOCIAL CAPITAL HEDOSOPH VI-A (IPOF) Stock Fundamental Analysis

NYSE:IPOF - New York Stock Exchange, Inc. - KYG8251L1059 - Common Stock - Currency: USD

10.03  0 (0%)

After market: 10.03 0 (0%)

Fundamental Rating

2

Overall IPOF gets a fundamental rating of 2 out of 10. We evaluated IPOF against 0 industry peers in the Unkown industry. IPOF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IPOF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IPOF was profitable.
IPOF Yearly Net Income VS EBIT VS OCF VS FCFIPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 10M 20M 30M 40M

1.2 Ratios

Industry RankSector Rank
ROA 5.37%
ROE 5.69%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPOF Yearly ROA, ROE, ROICIPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 1 2 3 4

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IPOF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPOF Yearly Profit, Operating, Gross MarginsIPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

4

2. Health

2.1 Basic Checks

IPOF has about the same amout of shares outstanding than it did 1 year ago.
IPOF has a worse debt/assets ratio than last year.
IPOF Yearly Shares OutstandingIPOF Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 50M 100M
IPOF Yearly Total Debt VS Total AssetsIPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 200M 400M 600M 800M 1B

2.2 Solvency

IPOF has an Altman-Z score of 13.69. This indicates that IPOF is financially healthy and has little risk of bankruptcy at the moment.
IPOF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.69
ROIC/WACCN/A
WACCN/A
IPOF Yearly LT Debt VS Equity VS FCFIPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.05 indicates that IPOF may have some problems paying its short term obligations.
IPOF has a Quick Ratio of 0.05. This is a bad value and indicates that IPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
IPOF Yearly Current Assets VS Current LiabilitesIPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.84% over the past year.
EPS 1Y (TTM)39.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPOF Yearly Revenue VS EstimatesIPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021
IPOF Yearly EPS VS EstimatesIPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.33, which indicates a rather expensive current valuation of IPOF.
When comparing the Price/Earnings ratio of IPOF to the average of the S&P500 Index (29.53), we can say IPOF is valued slightly cheaper.
Industry RankSector Rank
PE 23.33
Fwd PE N/A
IPOF Price Earnings VS Forward Price EarningsIPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPOF Per share dataIPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IPOF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOCIAL CAPITAL HEDOSOPH VI-A

NYSE:IPOF (10/14/2022, 8:04:00 PM)

After market: 10.03 0 (0%)

10.03

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.99%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.44B
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 23.33
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.43
EY4.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.57
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.37%
ROE 5.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 13.69
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A